Microbot Medical Inc [MBOT] stock is trading at $1.42, up 3.65%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The MBOT shares have gain 4.41% over the last week, with a monthly amount drifted -44.31%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Microbot Medical Inc [NASDAQ: MBOT] stock has seen the most recent analyst activity on January 13, 2020, when H.C. Wainwright reiterated its Buy rating and also boosted its price target to $26 from $12. Previously, H.C. Wainwright reaffirmed its Buy rating on December 24, 2019, and elevated its price target to $12. On January 31, 2018, Ladenburg Thalmann initiated with a Buy rating and assigned a price target of $1.75 on the stock.
Microbot Medical Inc [MBOT] stock has fluctuated between $0.82 and $3.38 over the past year. Microbot Medical Inc [NASDAQ: MBOT] shares were valued at $1.42 at the most recent close of the market.
Analyzing the MBOT fundamentals
Gross Profit Margin for this corporation currently stands at 0.46% with Operating Profit Margin at -72.27%, Pretax Profit Margin comes in at -78.91%, and Net Profit Margin reading is -78.91%. To continue investigating profitability, this company’s Return on Assets is posted at -2.15, Equity is -2.18 and Total Capital is -2.67. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.3633 points at the first support level, and at 1.3067 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.4733, and for the 2nd resistance point, it is at 1.5267.
Ratios To Look Out For
For context, Microbot Medical Inc’s Current Ratio is 3.64. As well, the Quick Ratio is 3.64, while the Cash Ratio is 0.35.
